申请人:Laboratoires Chauvin-Blache
公开号:US04665085A1
公开(公告)日:1987-05-12
Compounds having the formula (I) wherein R.sub.1 and R.sub.2 are a hydrogen atom, an alkyl group or a hydroxy group, or else R.sub.1 and R.sub.2 form together a bivalent ethylene or trimethylene radical; R.sub.3 is a halogen atom, an alkyl group, an alkoxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or di-alkyl amino group, an acetamido or sulfonamido group; R.sub.1 is a hydroxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or dialkyl amino group, an acetamido or sulfonamido group; R.sub.4 being in the position 3, 4 or 5 and A is a bridge having from 1 to 3 links selected among the groups having the formula (II), --NH--,--N.dbd.--O-- and --S--. R.sub.5 represents an hydrogen atom, an alkyl group, a hydroxy group or an alkoxy group as well as the addition salts thereof with pharmaceutically acceptable acids. Said compound may be used in therapeutical treatment as antihypertensive agents, particularly in the ocular field. ##STR1##
化合物的化学式为(I),其中R.sub.1和R.sub.2为氢原子、烷基或羟基,或者R.sub.1和R.sub.2共同形成二价乙烯或三甲基基;R.sub.3为卤素原子、烷基、烷氧基、单或多羟基烷基、氨基、单或双烷基氨基、乙酰胺基或磺酰胺基;R.sub.1为羟基、单或多羟基烷基、氨基、单或双烷基氨基、乙酰胺基或磺酰胺基;R.sub.4位于3、4或5位,A是一个桥,具有1到3个链,所选链在以下组中选择:(II)、--NH--、--N.dbd.--O--和--S--。R.sub.5表示氢原子、烷基、羟基或烷氧基,以及其与药用可接受酸的加合物。该化合物可用于治疗高血压,特别是在眼科领域中作为降压剂。